Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Journal of Nuclear Medicine Supplement summarizes current molecular radiotherapy

21.01.2005


Supplement projects future possibilities and partnering with patients in providing care



A special supplement to the Society of Nuclear Medicine’s Journal of Nuclear Medicine examines current and future uses of radionuclide therapy and its importance in medical practice and patient management.

Supplement editors Steven M. Larson, M.D., and Eric P. Krenning, M.D., Ph.D., present a comprehensive overview intended to offer relevant advice to nuclear medicine practitioners and other professionals who may be actively involved in radionuclide therapy and to provide them with a summary of suggested patterns of practice for common radionuclide therapies now available. They also include a forecast of the near-term opportunities that are likely to determine practice in the next few years.


Radionuclide therapy is an important and increasingly significant component of modern medical practice for a growing number of patients with thyroid cancer, lymphoma, metastatic bone involvement with prostate and breast cancer and carcinoid tumors, explained Larson, who is chief of nuclear medicine at Memorial Sloan-Kettering Cancer Center, New York, N.Y. Larson and Eric P. Krenning, M.D., Ph.D., Erasmus University Medical Center, Rotterdam, the Netherlands, are guest editors for the 204-page volume of "Clinical Practice of Molecular Radiotherapy," released in January.

In their introduction, Larson and Krenning note, "More and more, interested patients and their families will become partners in care in radionuclide therapy." To illustrate this and other points, the editors chose a dramatic photo for the cover symbolizing an important segment of the treatment population--women with thyroid cancer--one that has the distinction of being the most rapidly increasing in incidence in this country. "Nuclear medicine will play a growing role in the care of thyroid cancer and other tumors in the future," Larson said. Larson and Krenning also draw attention to the importance of cancer survivor groups in setting policy and promoting cancer awareness.

This essential resource includes the introduction, "A Pragmatic Perspective on Molecular Targeted Radionuclide Therapy," along with 26 articles (including black and white and color images) addressing future applications, conventional therapies, tumor-seeking peptides in therapy and tumor-seeking monoclonal antibodies. Articles include "Radiobiologic Principles in Radionuclide Therapy"; "The Evolving Role of 131I for the Treatment of Differentiated Thyroid Carcinoma"; "Bone-Seeking Radionuclides for Therapy"; "Radiosynovectomy in Rheumatology, Orthopedics and Hemophilia"; "Candidates for Peptide Receptor Radiotherapy Today and in the Future"; "Perspectives on Cancer Therapy With Radiolabeled Monoclonal Antibodies"; "The Promise of Immuno-PET in Radioimmunotherapy"; "Radiotargeted Gene Therapy"; and "Radiation Sensitizers: A Selective Review of Molecules Targeting DNA and non-DNA Targets."

"This supplement offers significant information for nuclear/molecular imaging professionals and deserves a place in your professional library," notes Heinrich R. Schelbert, M.D., Ph.D., editor of the Journal of Nuclear Medicine. JNM is the most prominent peer-reviewed journal in nuclear medicine, molecular imaging and allied disciplines. Not only does JNM rank among the top imaging journals, its impact factor puts it in the top 5 percent of all scientific serials rated by the Institute for Scientific Information. Published monthly, JNM features clinical investigations and basic science papers, continuing education articles, book reviews, an event calendar and an employment section.

Maryann Verrillo | EurekAlert!
Further information:
http://www.snm.org
http://jnm.snmjournals.org

More articles from Health and Medicine:

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht On track to heal leukaemia
18.01.2017 | Universitätsspital Bern

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

New Study Will Help Find the Best Locations for Thermal Power Stations in Iceland

19.01.2017 | Earth Sciences

Not of Divided Mind

19.01.2017 | Life Sciences

Molecule flash mob

19.01.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>